Shangpin China Specialty Website construction On November 16, 2015, Shangpin China signed a contract with Tsinghua University's High Precision Innovation Center for Structural Biology.
The 21st century is the century of life science, and structural biology is one of the frontier mainstream disciplines of modern life science research. The in-depth study of the structure and function of biomacromolecules can not only solve a series of major basic scientific problems, help people better understand the essence of life phenomena, but also is closely related to human health, which will greatly promote the research and development of new drugs based on the structure of biomacromolecules. Structural biology research has an excellent tradition in China. In the 1960s and 1970s, structural biology research in China once took the lead in the world, keeping pace with the United States and Britain. For example, the high-resolution insulin crystal structure measurement completed by the Beijing Insulin Research Group in the 1970s represented the advanced level of the world at that time. Since the new century, a group of domestic research institutions represented by Tsinghua University and the Institute of Biophysics of the Chinese Academy of Sciences have made outstanding achievements.
The High Precision Innovation Center for Structural Biology of Tsinghua University, organized by the Beijing Municipal Education Commission, is one of the first 13 high precision innovation centers in Beijing. With Tsinghua University as the support and leading unit, the Center was jointly built with Beijing University of Technology. Tsinghua University is an important base for higher education, scientific research and technological development in China. It is responsible for cultivating high-level talents, achieving high-level scientific research achievements and promoting national economic construction. The structural biology team of Tsinghua University gathers, grows, expands and gradually demonstrates its international influence on the basis of the previous generation in this century's rare historical opportunity. The first director of the center is the world famous structural biologist Professor Shi Yigong. At present, there are 20 independent laboratories, more than 40 post doctors and more than 200 doctoral students. The research work covers many frontier fields of modern structural biology, including biological macromolecule machines, disease related membrane proteins, tumor suppressors Research on the structure and function of important biological macromolecules such as apoptosis regulating protein and diabetes drug target protein, and have made a series of work with international influence. In 2015, the Center published 11 high-level research papers in Nature, Science and Cell with Tsinghua University as the corresponding author, and dozens of papers in other international journals, which had a great international impact and contributed to the development of structural biology in China.
Relying on the Beijing Municipal Education Commission, integrating the advantages of Tsinghua University and Beijing University of Technology, the Advanced Innovation Center of Structural Biology provides an optimal carrier for structural biology and health industry. By integrating the advantages of multiple disciplines, organically integrating the development of technology and methods with the application of basic scientific research and later transformation, the Center will be likely to invent a series of original and far-reaching new technologies and methods of structural biology in the next 5-10 years. The main task of the center is to explore interdisciplinary, inter university cooperation, cooperation between universities and local governments, organically integrate technology development, basic research, and achievement transformation, build a world leading structural biology center for a long time, produce a batch of original scientific achievements that have influence in the history of science, and on the basis of basic research and technology development, Promote the development of health related industries such as biotechnology and biopharmaceutical industry in Beijing, and build a good platform for Chinese biologists to integrate into the international arena.
